Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3

Sponsor Class

NETWORK 3OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Sarcoma 3Other hematologic neoplasm 3Lymphoid 3Head & Neck 3CNS 3Plasma cell 1Other neoplasm 1Myeloid 1Genitourinary 1Breast 1

Conditions

Sarcoma 2Osteosarcoma 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Radiotherapy 35Doxorubicin 30Ifosfamide 29Cyclophosphamide 24Vincristine 23Filgrastim 23Etoposide 20Temozolomide 14Granulocyte Colony-Stimulating Factor 14Dactinomycin 11Cisplatin 11Trabectedin 10Methotrexate 10Gene Expression Profiling 10Radiation 9Imatinib Mesylate 9Surgical Procedures, Operative 8Polymerase Chain Reaction 8Irinotecan 8Specimen Handling 7Paclitaxel 7Chemotherapy, Adjuvant 7Mesna 6Immunohistochemistry 6Gemcitabine 6Carmustine 6Biopsy 6sargramostim 5pegfilgrastim 5etoposide phosphate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × In Situ Hybridization, Fluorescence × Sarcoma × Clear all
NCT01466283 2016-05-19

Biomarkers in Patients With Rhabdomyosarcoma

Children's Oncology Group

Completed
20 enrolled
Sarcoma

Sarcoma

NCT01139983 2016-05-18

DNA Biomarkers in Samples From Patients With Osteosarcoma and Healthy Volunteers

Children's Oncology Group

Completed
90 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT00424060 2012-09-24

Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
38 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡